DESCRIPTION
NGENLA treatment should be supervised by a healthcare provider who is experienced in the diagnosis and management of pediatric patients with growth hormone deficiency (2.1).
•
Administer NGENLA by subcutaneous injection once weekly, on the same day each week, at any time of the day in the abdomen, thighs, buttocks, or upper arms with weekly rotation of injection site (2.1).
•
The recommended dosage is 0.66 mg/kg based on actual body weight administered once weekly (2.3).
•
Individualize dosage for each patient based on the growth response (2.3).
•
Patients switching from daily growth hormone may initiate treatment with once-weekly NGENLA on the day following their last daily injection (2.3).
•
If more than one injection is required to deliver a complete dose, each injection should be administered at a different injection site
